Overview

The Efficacy and Safety of Tofacitinib in Patients With Glucocorticoid Resistant ICIs-related Myocarditis

Status:
NOT_YET_RECRUITING
Trial end date:
2026-11-30
Target enrollment:
Participant gender:
Summary
The efficacy and safety of Tofacitinib in patients with glucocorticoid resistant ICIs-related myocarditis: a single-arm, prospective, phase 2 trial
Phase:
PHASE2
Details
Lead Sponsor:
Shanghai Zhongshan Hospital
Treatments:
BID protein, human
tofacitinib